Compare ASMB & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | CBAN |
|---|---|---|
| Founded | 2005 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 436.3M |
| IPO Year | 2010 | 1995 |
| Metric | ASMB | CBAN |
|---|---|---|
| Price | $28.57 | $19.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $43.40 | N/A |
| AVG Volume (30 Days) | 91.6K | ★ 161.1K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 50.00 | 9.68 |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | N/A |
| Revenue This Year | $33.33 | $35.41 |
| Revenue Next Year | N/A | $4.84 |
| P/E Ratio | ★ N/A | $16.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.76 | $13.99 |
| 52 Week High | $39.71 | $21.46 |
| Indicator | ASMB | CBAN |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 47.08 |
| Support Level | $26.50 | $15.96 |
| Resistance Level | $31.11 | $21.25 |
| Average True Range (ATR) | 1.84 | 0.61 |
| MACD | 0.11 | -0.14 |
| Stochastic Oscillator | 57.55 | 30.08 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.